A5056390133- Lung Cancer Research Studies
- Neuroendocrine Tumor Research Advances
- Pituitary Gland Disorders and Treatments
- Renal cell carcinoma treatment
- Growth Hormone and Insulin-like Growth Factors
- Dermatology and Skin Diseases
- Economic and Financial Impacts of Cancer
- Neuroblastoma Research and Treatments
- Tuberous Sclerosis Complex Research
- Bone health and treatments
- Renal and related cancers
- Allergic Rhinitis and Sensitization
- Cancer Genomics and Diagnostics
- Lung Cancer Treatments and Mutations
- Adrenal and Paraganglionic Tumors
- Adrenal Hormones and Disorders
- Asthma and respiratory diseases
- Food Allergy and Anaphylaxis Research
- Cancer Treatment and Pharmacology
- Cancer Diagnosis and Treatment
- Urinary Tract Infections Management
- Gestational Trophoblastic Disease Studies
- Health Systems, Economic Evaluations, Quality of Life
- Multiple and Secondary Primary Cancers
- Polyomavirus and related diseases
Janssen (United States)
2024-2025
Pfizer (United States)
2019-2024
Novartis (United States)
2012-2019
Novartis (Switzerland)
2012-2019
Analysis Group (United States)
2006-2017
Tris Pharma (United States)
2012-2017
Partnership for Health Analytic Research
2017
Menlo School
2017
GlaxoSmithKline (United States)
2007-2015
GlaxoSmithKline (United Kingdom)
2007-2014
Understanding what constitutes an important difference on a HRQL measure is critical to its interpretation. The aim of this study was provide range estimates minimally differences (MIDs) in EQ-5D scores cancer and determine if are comparable lung cancer. A retrospective analysis conducted cross-sectional data collected from 534 patients, 50 whom were patients. index-based utility (UK US) VAS estimated using both anchor-based distribution-based (1/2 standard deviation error the measure)...
Incidence and prevalence estimates of acromegaly in the United States (US) are limited. Most existing reports based on European data sources. The objective this study was to estimate annual incidence a large US managed care population, overall stratified by age, sex, geographic region, using from 2008 2012.Using administrative claims data, commercial health plan enrollees were identified with if they had two or more medical an diagnosis code (ICD-9-CM: 253.0×) one claim combination other for...
Abstract Angiogenesis inhibitors have become standard of care for advanced and/or metastatic renal cell carcinoma ( RCC ), but data on the impact adverse events AE s) and treatment modifications associated with these agents are limited. Medical records were abstracted at 10 tertiary oncology centers in Europe 291 patients ≥18 years old treated sunitinib as first‐line (no prior systemic disease). Logistic regression models estimated to compare dose intensity among who did not experience s...
Abstract Background Little is known about the risk of invasive E. coli disease (IED) after elective urologic procedures with or without antibiotic prophylaxis. This study aimed to estimate IED selected in patients prophylaxis, and controls who had no nor other procedures.Table 1.Patient demographic clinical characteristics Methods The Komodo Research Database (01/01/2021–06/30/2023) was used identify ≥60 years old prostate biopsy, endoscopy, nephrostomy (index: first procedure date), a 1:3...
Abstract Background Extraintestinal pathogenic E. coli (ExPEC) are often treated with multiple classes of antibiotics, however, real-world treatment patterns poorly characterized. We sought to identify evidence about treatments used for adult patients infected ExPEC in the US. Figure 1 PRISMA flowchart Methods A systematic literature review was conducted EMBASE, MEDLINE, and MEDLINE In-Process databases US studies infections real world settings, published Jan. 2010–Sept. 2023. 2 Antibiotic...
Abstract Background Invasive E. coli disease (IED) poses a substantial public health concern globally. Anti-microbial resistance (AMR) displayed by some strains further limits the treatment options. We sought to identify and synthesize evidence on prevalence of AMR among adult IED patients in United States. Figure 1. PRISMA flowchart Methods A systematic literature review was conducted EMBASE, MEDLINE, MEDLINE In-Process databases studies patients, published January. 2010–September. 2023. 2....
Little is known about the risk of invasive E. coli disease (IED) after elective urologic procedures. We estimated IED selected procedures in patients with or without antibiotic prophylaxis, and controls no other surgical The Komodo Research Database (01/01/2021-06/30/2023) was used to identify ≥ 60 years old urological (index: first procedure date) randomly random date). Patients were classified into two cohorts based on whether not they received prophylaxis within 14 days prior index date....
Invasive Escherichia coli disease (IED) incidence has increased over recent years among aging populations and rising antimicrobial resistance. Here, we report on a comparative, cross-sectional, retrospective analysis of US patients with IED to quantify IED-related healthcare resource utilization (HCRU), costs, impact health-related quality life (HRQoL). This study included Kaiser Permanente Northwest (KPNW) members aged ≥ 60 enrolled between July 2019 January 2020. Patients were divided into...
Comparison of upright inspiratory and expiratory chest radiographs for detecting pneumothoraces.A Seow, E A Kazerooni, P G Pernicano M NearyAudio Available | Share
To assess the effectiveness, safety, and treatment patterns of anti-angiogenic agents in metastatic renal cell carcinoma (mRCC) tertiary clinical practice settings.We retrospectively reviewed medical records two oncology centres USA for all patients treated while off trials from April 2003 to June 2008 who met entry criteria received one or more prescriptions sunitinib sorafenib, intravenous administrations bevacizumab (off-label) as first-line treatment. The objective response rate (ORR) by...
We wish to correct a mistake in the abstract and conclusion of our published paper [1].In conclusion, MID for EQ-VAS score should be reported as 7 rather than 0.07.EQ-VAS scores range from 0 100, while EQ-5D index-based are anchored by (dead) 1 (perfect health).The specific wording read "Important differences utility VAS were similar all cancers lung cancer, with lower end estimates closer MID, i. e. 0.08 UK-index scores, 0.06 US-index scores.
There is a need to compare efficacy and safety profiles of crisaborole ointment, 2%, versus other topical treatments across randomized clinical trials (RCTs). We performed this review/network meta-analysis evaluate the comparative pharmacologic therapies for mild-to-moderate atopic dermatitis (AD) among patients aged ≥ 2 years. Searches were conducted in MEDLINE, Embase, Cochrane Collection Central Register Clinical Trials, Database Abstracts Reviews Effects using Ovid identify English...
Abstract BACKGROUND Bisphosphonates have been used to treat bone metastases in hormone‐refractory prostate cancer (HRPC), but certain agents associated with renal toxicity. For this observational study, the authors assessed risk of impairment patients HRPC who received zoledronic acid from December 1999 April 2005. METHODS A comprehensive medical records review was performed a major tertiary oncology center (n = 122 patients). The primary outcome defined as an increase ≥0.5 mg/dL or ≥1.0...